Markets
Leaderboard
Which Covid-19 vaccine will be the first to be distributed in Brazil (regardless of emergency or regular approval)? Sinovac: real money 63%, play money 99% Other: real money 9%, play money 1% BionTech/Pfizer: real money 9%, play money 1% Oxford/AstraZeneca: real money 9%, play money 1% Janssen: real money 9%, play money 1% Volume: real money 239.939441, play money 35244.26 Bettors: real money 3, play money 194 Categories: Science, Transmissible Diseases, Covid-19 (Coronavirus), Vaccine Related markets Nipah virus declared a public health emergency by the WHO in 2026? (ID: 233776) Volume: real 28.46718558, play 4933.4347 Bettors: real 6, play 3 Leading (real money): Nipah virus declared a public health emergency by the WHO in 2026? 6% Leading (play money): Nipah virus declared a public health emergency by the WHO in 2026? 6% Antarctic sea ice minimum to decrease in 2027? (ID: 235045) Volume: real 0.30038449, play 0.1 Bettors: real 5, play 2 Leading (real money): Antarctic sea ice minimum to decrease in 2027? 81% Leading (play money): Antarctic sea ice minimum to decrease in 2027? 81%

Which Covid-19 vaccine will be the first to be distributed in Brazil (regardless of emergency or regular approval)?

Market Rules

As of October, 2020, Brazil had four vaccine candidates being tested in its territory, from the following companies: Sinovac (China), AstraZeneca/Oxford (England), BionTech/Pfizer (USA/German), and Janssen Pharmaceuticals (USA). They were all in phase III trials, and still recruiting volunteers.

Due to agreements between these companies and Brazil's government, any vaccine tested in the country has a head start to become the first to be distributed for the population, given that its safety and effectiveness is proven. But there is still a chance that none of them will be "The Chosen One", and a different vaccine is approved first.

The alternative that mentions the name of company whose vaccine is the first one to be distributed in Brazil to any group that is not part of the phase III trials will be considered the winning outcome of this market. It is irrelavant for that is the approval for its distribution is a regular approval or an emergency approval.

People also viewed